NASDAQ:CDT - US20678X3044 - Common Stock
The current stock price of CDT is 1.68 USD. In the past month the price decreased by -16%. In the past year, price decreased by -99.32%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 22.84 | 188.80B | ||
DHR | DANAHER CORP | 28.13 | 151.66B | ||
A | AGILENT TECHNOLOGIES INC | 22.52 | 34.55B | ||
IQV | IQVIA HOLDINGS INC | 16.67 | 32.50B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 32.31 | 27.22B | ||
WAT | WATERS CORP | 24.71 | 17.99B | ||
WST | WEST PHARMACEUTICAL SERVICES | 35.61 | 17.82B | ||
ILMN | ILLUMINA INC | 24.47 | 15.65B | ||
TEM | TEMPUS AI INC | N/A | 13.99B | ||
ICLR | ICON PLC | 13.29 | 13.67B | ||
MEDP | MEDPACE HOLDINGS INC | 34.47 | 13.02B | ||
RVTY | REVVITY INC | 19.25 | 10.93B |
Conduit Pharmaceuticals Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Naples Florida, Florida and currently employs 6 full-time employees. The company went IPO on 2022-02-03. Conduit Pharmaceuticals, Inc. is a multi-asset clinical-stage, life science company. The firm facilitates the development and commercialization of clinical assets. The firm acquires and funds the development of Phase 2-ready assets, builds an integrated and advanced platform-driven approach powered by artificial intelligence (AI) and cybernetics, and seeks exit through third-party license deals following successful clinical trials. The Company’s asset pipeline includes AZD1656 (a Glucokinase Activator), AZD5658 (Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. The company is used as a treatment option for Hashimoto’s Thyroiditis. AZD5904 includes a potent, irreversible inhibitor of human myeloperoxidase (MPO), for the treatment, prevention, and prophylaxis of idiopathic male infertility.
CDT EQUITY INC
4851 Tamiami Trail North, Suite 200
Naples Florida FLORIDA US
Employees: 6
Phone: 16464919132
The current stock price of CDT is 1.68 USD. The price increased by 9.09% in the last trading session.
The exchange symbol of CDT EQUITY INC is CDT and it is listed on the Nasdaq exchange.
CDT stock is listed on the Nasdaq exchange.
CDT EQUITY INC (CDT) has a market capitalization of 5.14M USD. This makes CDT a Nano Cap stock.
CDT EQUITY INC (CDT) currently has 6 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CDT does not pay a dividend.
CDT EQUITY INC (CDT) will report earnings on 2025-11-10.
CDT EQUITY INC (CDT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-164.39).
The outstanding short interest for CDT EQUITY INC (CDT) is 2.55% of its float. Check the ownership tab for more information on the CDT short interest.
ChartMill assigns a fundamental rating of 1 / 10 to CDT. CDT has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months CDT reported a non-GAAP Earnings per Share(EPS) of -164.39. The EPS decreased by -33448.06% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -264.94% | ||
ROE | -721.85% | ||
Debt/Equity | 0.99 |